Perceive Pharma
Perceive Pharma operates as a pharmaceutical company. Perceive Pharma develops innovative small molecule neuroprotective treatments.
$15M
Latest Funding
Series A
Latest Funding Stage
2025-02-18
Funding Date
$15M
Total Funding
17
Employees
United States
Location
San Francisco, California
City & State
Sales-Ready Summary
Perceive Bio recently raised a $15M Series A round, indicating new budget for growth. Their tech stack includes WordPress and other marketing tools, suggesting they could benefit from enhanced content management and marketing automation solutions.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Ignota Labs
Ignota Labs recognizes that safety errors during the drug discovery process can result in expensive setbacks and delays in bringing life-changing medications to market. Ignota Labs world leading AI methods, which include deep learning and machine learning approaches, are intended to examine complicated molecular data and provide accurate toxicitypredictions.
Monument Therapeutics
Monument Therapeutics medical approach utilizes proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, enabling researchers to focus on the advancement of neuroscience drugs in areas of unmet medical needs.
EG 427
EG 427 develops HSV-1-based vectors by exploiting the natural properties of Herpes Simplex Virus 1 (HSV-1) and its ability to establish lifelong latency in peripheral neurons to ensure highly specific and durable expression of transgenes to treat patients with severe, chronic and localized diseases, enabling physicians to cure neurogenic bladder disorders post a spinal cord injury.